R-GAT: cancer document classification leveraging graph-based residual network for scenarios with limited data
Elias Hossain1, Tasfia Nuzhat2, Shamsul Masum3
1Department of Computer Science and Engineering, Mississippi State University, Starkville, MS, 39762, USA. mh3511@msstate.edu.
Scientific Reports
|February 17, 2026
Summary
A new Residual Graph Attention Network (R-GAT) efficiently classifies cancer abstracts. This lightweight model offers performance comparable to complex transformers with fewer computational resources, aiding cancer informatics research.
Area of Science:
- Biomedical Natural Language Processing (NLP)
- Cancer Informatics
- Machine Learning for Healthcare
Background:
- Accurate classification of cancer-related biomedical abstracts is vital for cancer informatics and healthcare research.
- Limited labeled data and high computational costs of transformer models hinder progress in this field.
Purpose of the Study:
- To develop a computationally efficient and effective model for classifying cancer-related biomedical abstracts.
- To address the limitations of existing methods in terms of data requirements and computational resources.
Main Methods:
- Proposed a Residual Graph Attention Network (R-GAT) integrating multi-head attention and residual connections.
- Captured semantic and relational dependencies within biomedical texts.
- Evaluated the model on a curated dataset of 1,875 PubMed abstracts covering thyroid, colon, lung, and generic cancer topics.
Main Results:
- R-GAT achieved a macro-F1 score of 0.96 ± 0.01, demonstrating stable and competitive performance.
- Performance was comparable to transformer-based models (BioBERT, BioClinicalBERT) and classical baselines (Logistic Regression).
- R-GAT required significantly fewer computational resources than transformer models.
Conclusions:
- Lightweight graph-based architectures like R-GAT are reliable and resource-efficient alternatives to computationally intensive transformers in biomedical NLP.
- Attention mechanisms and residual connections are crucial for model robustness, especially with limited data.
- The curated dataset is released to promote reproducibility and further research in cancer informatics.
Related Concept Videos
Cancer Survival Analysis
787
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
787
Cancer-Critical Genes II: Tumor Suppressor Genes
9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Kaplan-Meier Approach
643
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
643
